Investors looking for another hemp play might consider Charlotte's Web Holdings, which deals in a range of CBD wellness products.
A key aspect of the international expansion is the company's recent acquisition of hemp-food producer Manitoba Harvest in February.
Apparently, this game is all about growth right now. It certainly is not about margins.
Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.
Let's check out the charts and indicators for this so-called pot play.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Recently uplisted CTST is a huge player in the medical marijuana market.
You may want to check out GW Pharmaceuticals and Elixinol Global Limited.
This quarter is a heavy test for Tilray because of the stock's lofty valuation.
Assessing Aurora and its peers, strictly on the numbers.